This International Immunosuppression Summit will bring together scientists to discuss the problems associated with natural and induced immunosuppression.
A late registration fee applies after January 20th 2016
Who should attend
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy.
Abstracts for poster presentation only
can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation